Navigation Links
Posit Science is Best in Brain Fitness Says Best Life
Date:12/15/2008

decline in health related quality of life; better driving abilities and lower crash risk.

Posit Science programs are used in hundreds of retirement communities and adult education programs across North America, and more than 100,000 copies have been purchased for use by individuals in their homes. The company's products, scientists and science are currently featured in the PBS documentaries "The Brain Fitness Program" and "Brain Fitness 2: Sight and Sound."

About Posit Science:

Posit Science is the leading provider of clinically validated brain fitness programs. The company works with more than 50 scientists from prestigious universities to design and test its computer-based programs. More than 30 published papers show that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention, and enhance the quality of everyday life. Posit Science has received grants from the National Institutes of Health and has received numerous awards and accolades. For more information, visit http://www.PositScience.com or call 1-866-599-6463.


'/>"/>
SOURCE Posit Science
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genetic predisposition increases childhood asthma risk
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
4. CCRKBA Backs Sen. Coburns Opposition to Tenets of H.R. 327
5. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
6. Nutrition model stresses positive experience of eating
7. Muscle patterns in women may be linked to at risk positioning for ACL tears
8. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
9. Ultrasound plus mammography finds more cancers, but increases false positives
10. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
11. CNS Response, Inc. Appoints George C. Carpenter IV to Position of President
Post Your Comments:
*Name:
*Comment:
*Email: